Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves?


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
05 03 2022
Historique:
received: 11 01 2022
revised: 17 02 2022
accepted: 04 03 2022
entrez: 26 3 2022
pubmed: 27 3 2022
medline: 1 4 2022
Statut: epublish

Résumé

Profound clinical differences between the first and second waves of COVID-19 were observed in Europe. Nitric oxide (NO) may positively impact patients with Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) infection. It is mainly generated by inducible nitric oxide synthase (iNOS). We studied serum iNOS levels together with serum interleukin (IL)-6 and IL-10 in patients with SARS-CoV-2 infection in the first wave (

Identifiants

pubmed: 35336941
pii: v14030534
doi: 10.3390/v14030534
pmc: PMC8948744
pii:
doi:

Substances chimiques

Nitric Oxide 31C4KY9ESH
NOS2 protein, human EC 1.14.13.39
Nitric Oxide Synthase Type II EC 1.14.13.39

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Regione Campania
ID : CEINGE-TASK-force COVID-19, code D64I200003800
Organisme : Italian Ministry of University and Research
ID : PRIN 2020, code 20209TB4AX

Références

Nitric Oxide. 2010 Sep 15;23(2):75-93
pubmed: 20438856
N Engl J Med. 2022 Feb 10;386(6):509-520
pubmed: 34914868
Nitric Oxide. 2020 Oct 1;103:4-8
pubmed: 32681986
Front Physiol. 2012 Jun 25;3:218
pubmed: 22737132
Ann Thorac Surg. 2005 Jan;79(1):16-20
pubmed: 15620907
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
Front Immunol. 2018 Mar 13;9:302
pubmed: 29593707
Infect Dis (Lond). 2021 May;53(5):370-375
pubmed: 33560897
J Clin Pathol. 1998 Oct;51(10):750-3
pubmed: 10023337
Br J Pharmacol. 2019 Jan;176(2):246-255
pubmed: 30288739
Crit Care Med. 2021 Jan 1;49(1):e11-e19
pubmed: 33148952
Nitric Oxide. 2011 Aug 1;25(2):138-44
pubmed: 21440655
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Int J Biol Sci. 2020 Jun 27;16(13):2382-2391
pubmed: 32760206
Clin Chem Lab Med. 2020 Jun 25;58(7):1162-1164
pubmed: 32333649
Obstet Gynecol. 2020 Dec;136(6):1109-1113
pubmed: 32852324
N Engl J Med. 2022 Jan 27;386(4):305-315
pubmed: 34937145
Exp Gerontol. 2006 Nov;41(11):1165-73
pubmed: 17049787
Biochem Biophys Res Commun. 1992 Feb 14;182(3):1155-9
pubmed: 1371674
N Engl J Med. 2020 Oct 29;383(18):1757-1766
pubmed: 32329974
Drug Saf. 2020 Aug;43(8):691-698
pubmed: 32696429
Int J Environ Res Public Health. 2020 Nov 24;17(23):
pubmed: 33255181
Endocrinology. 2019 Oct 1;160(10):2395-2400
pubmed: 31199478
N Engl J Med. 2020 Dec 17;383(25):2451-2460
pubmed: 32412710
J Med Virol. 2022 May;94(5):2222-2229
pubmed: 35088444
Curr Drug Targets Inflamm Allergy. 2002 Mar;1(1):89-108
pubmed: 14561209
Life Sci. 2020 Nov 15;261:118355
pubmed: 32871183
Am J Respir Crit Care Med. 2020 Jul 1;202(1):16-20
pubmed: 32437250
Environ Res. 2021 Apr;195:110856
pubmed: 33581086
Acta Anaesthesiol Scand. 2021 May;65(5):576-577
pubmed: 33533477
Crit Care. 2020 Nov 12;24(1):645
pubmed: 33183348
BMJ. 2021 Nov 8;375:n2713
pubmed: 34750163
Trends Microbiol. 1995 Mar;3(3):81-2
pubmed: 7773591
Front Immunol. 2020 Sep 30;11:556579
pubmed: 33117343
Aging Clin Exp Res. 2021 Jan;33(1):193-199
pubmed: 33345291

Auteurs

Monica Gelzo (M)

Ceinge-Biotecnologie Avanzate s.c.a.r.l., 80145 Naples, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.

Filippo Scialò (F)

Ceinge-Biotecnologie Avanzate s.c.a.r.l., 80145 Naples, Italy.
Dipartimento di Medicina Traslazionale, Università della Campania L. Vanvitelli, 80131 Naples, Italy.

Sara Cacciapuoti (S)

Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, 80131 Naples, Italy.

Biagio Pinchera (B)

Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, 80131 Naples, Italy.

Annunziata De Rosa (A)

Dipartimento di Malattie Infettive e Emergenze Infettive, Divisione di Malattie Infettive Respiratorie, Ospedale Cotugno, AORN dei Colli, 80131 Naples, Italy.

Gustavo Cernera (G)

Ceinge-Biotecnologie Avanzate s.c.a.r.l., 80145 Naples, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.

Marika Comegna (M)

Ceinge-Biotecnologie Avanzate s.c.a.r.l., 80145 Naples, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.

Lorella Tripodi (L)

Ceinge-Biotecnologie Avanzate s.c.a.r.l., 80145 Naples, Italy.

Nicola Schiano Moriello (N)

Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, 80131 Naples, Italy.

Mauro Mormile (M)

Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, 80131 Naples, Italy.

Gabriella Fabbrocini (G)

Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, 80131 Naples, Italy.

Roberto Parrella (R)

Dipartimento di Malattie Infettive e Emergenze Infettive, Divisione di Malattie Infettive Respiratorie, Ospedale Cotugno, AORN dei Colli, 80131 Naples, Italy.

Gaetano Corso (G)

Ceinge-Biotecnologie Avanzate s.c.a.r.l., 80145 Naples, Italy.
Dipartimento di Medicina Clinica e Sperimentale, Università di Foggia, 71122 Foggia, Italy.

Ivan Gentile (I)

Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, 80131 Naples, Italy.

Giuseppe Castaldo (G)

Ceinge-Biotecnologie Avanzate s.c.a.r.l., 80145 Naples, Italy.
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH